Randomization for the susceptibility effect of an infectious disease intervention
Daniel J. Eck, Olga Morozova, Forrest W. Crawford

TL;DR
This paper demonstrates that standard randomized trial designs may mislead conclusions about an infectious disease intervention's effectiveness due to interference and contagion effects, highlighting the need for careful analysis.
Contribution
The paper reveals that the commonly used direct effect measure can fail to indicate the true susceptibility effect in contagious disease trials, using a novel probabilistic coupling approach.
Findings
Direct effect may not reflect the true susceptibility effect in contagious settings
Randomization can lead to misleading inferences about intervention efficacy
Structural and probabilistic methods clarify transmission dynamics
Abstract
Randomized trials of infectious disease interventions, such as vaccines, often focus on groups of connected or potentially interacting individuals. When the pathogen of interest is transmissible between study subjects, interference may occur: individual infection outcomes may depend on treatments received by others. Epidemiologists have defined the primary causal effect of interest -- called the "susceptibility effect" -- as a contrast in infection risk under treatment versus no treatment, while holding exposure to infectiousness constant. A related quantity -- the "direct effect" -- is defined as an unconditional contrast between the infection risk under treatment versus no treatment. The purpose of this paper is to show that under a widely recommended randomization design, the direct effect may fail to recover the sign of the true susceptibility effect of the intervention in a…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · Vaccine Coverage and Hesitancy · SARS-CoV-2 and COVID-19 Research
